Latest return on equity
Cadrenal Therapeutics Return on equity
Direct answer
Cadrenal Therapeutics's return on equity is -275.16%.
The verified market snapshot reports -275.16%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 26, 2026.
Get free Cadrenal Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -275.16%
Explore related company data
View Cadrenal Therapeutics's market capitalizationView Cadrenal Therapeutics's price-to-book ratioView Cadrenal Therapeutics's dividend yieldView Cadrenal Therapeutics's 52-week price rangeView Cadrenal Therapeutics's profit marginView all Cadrenal Therapeutics key metricsReturn to Cadrenal Therapeutics profile